Selective inhibition of the TLR2 pathway decreased neuronal apoptosis, inhibited the hippocampal activation of NF-κB and microglial inflammation, and protected cognitive function in an AD mouse model [152]. This evidence concerns the gene NFKB1 and Alzheimer disease.